About Us
One of leading players in marketing traditional and modern medicines, H.aidrab Pharma deals in a wide range of pharma products relating to areas like Dietary Supplements, Indian Traditional Medicine and Modern Allopathic medicines. Established in 1995, Hyderabad headquartered H.aidrab Pharma has journeyed the path of excellence and quality in marketing cost effective pharma products that covers almost every major divisions of health area.

Founder Bimal Baradia has over three decades of experience in pharmaceuticals segment. Under his inspiring leadership, H.aidrab Pharma has emerged as a leading marketing company engaged in pharmaceutical segment covering a rich portfolio of products. Today the company ranks among the leading names in pharmaceuticals marketing and enjoys a healthy market presence with products like Pentarab, Calskoop, Escan-150, Spascure, Lobus-25, Nuroskoop Forte, etc in Allopathic segment, Nuroskoop Plus, Zaidiff-XT, Skoop, etc in Dietary Supplements segment and Skoop-A and Natliv in Indian Traditional Medicine segment.


Our business model based on careful planning and sound understanding of people's medical needs that allows to respond with alacrity to market requirements and maintain an edge over our peers in the markets where we are present. All our products confirms to the most stringent international quality norms.

We look to venture into newer areas and where possible, actively seek opportunities to market our products through innovative line extensions.

Vision
To leverage our capabilities in niche and superior products that will consistently meet our clients' expectations.
Mission
To enrich people's lives through innovative marketing practices and work for a healthier world.
Quality
H.aidrab Pharma is a quality-driven Pharmaceutical Marketing Company that accords the highest importance to quality.

All our products are from renowned manufacturers that own state-of-the-art manufacturing facility with quality checks in place at every strategic point, in accordance to stringent WHO-GMP guidelines.